TrialRadiation oncology (London, England)2019

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.

Liangzhi Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.